DURECT

1 follower

‌

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Industries

Pharmaceutical

Headquarters

Cupertino, United States

Employees

51-200

Links

Org chart

James E. Brown

President & CEO

James E. Brown

Collapse

Norman L. Sussman

Chief Medical Officer

Judy Joice

SVP, Operations & Corporate Quality Assurance

David J. Ellis

VP, Clinical Development

Steve Helmer

Vice President, Chief Patent Counsel

Weiqi Lin

EVP, Research & Development & Principal Scientist

Dorothy Engelking

VP, Regulatory Affairs

Jim Brown

Pres/ceo

Charlie Claycomb

Executive Director Information Technology

Susan Autio

Exe. Director Engineering Manufacturing Development & Clinical Packaging

Crystal Susa

Manager, Intellectual Property Support

John Gibson

VP Birmingham Operations

Pete Garcia

Member Board Of Directors

Timothy M. Papp

CFO

Teams

Leadership Team

10 members

Scientific Research and Development

10 members

Director Team

9 members

Manufacturing and Production

4 members

Operations and Support

4 members

Quality Assurance Team

3 members

Similar companies

Azurity Pharmaceuticals

4 followers

Xeris Pharmaceuticals

2 followers

Rancho BioSciences

2 followers

Catalyst Pharmaceuticals

2 followers

Crinetics Pharmaceuticals

1 follower

Providence Medical Technology

1 follower

CorMedix

1 follower

Leadiant Biosciences

1 follower

Sight Sciences

2 followers

OM1

2 followers

cGMP Validation LLC

1 follower

Explore companies